Thus, it would be valuable to test the effect of TNFR2 blockade on Tregs and other CD4+ T cell subpopulations and on the levels of cytokines they produce to potentially uncover biological mechanisms that may help develop novel therapeutic strategies to treat RA or other autoimmune diseases. Here, TNFRSF1B is linked to autoimmune disease.